ZA939456B - Compounds - Google Patents
CompoundsInfo
- Publication number
- ZA939456B ZA939456B ZA939456A ZA939456A ZA939456B ZA 939456 B ZA939456 B ZA 939456B ZA 939456 A ZA939456 A ZA 939456A ZA 939456 A ZA939456 A ZA 939456A ZA 939456 B ZA939456 B ZA 939456B
- Authority
- ZA
- South Africa
- Prior art keywords
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929226537A GB9226537D0 (en) | 1992-12-21 | 1992-12-21 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA939456B true ZA939456B (en) | 1995-06-19 |
Family
ID=10726916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA939456A ZA939456B (en) | 1992-12-21 | 1993-12-17 | Compounds |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0674620A1 (en) |
| JP (1) | JPH08504786A (en) |
| CN (1) | CN1092765A (en) |
| AU (1) | AU5811994A (en) |
| GB (1) | GB9226537D0 (en) |
| WO (1) | WO1994014771A1 (en) |
| ZA (1) | ZA939456B (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2273328C (en) * | 1996-11-26 | 2009-04-28 | Abdelmalik Slassi | 5-cyclo indole compounds as 5-ht1d receptor ligands |
| ATE252572T1 (en) * | 1998-06-30 | 2003-11-15 | Lilly Co Eli | 5-HT1F AGONISTS |
| CA2375909A1 (en) | 1999-07-19 | 2001-01-25 | Shionogi & Co., Ltd. | Tricyclic compounds bearing acyloxymethoxycarbonyl pendants |
| AU7962200A (en) * | 1999-10-29 | 2001-05-14 | Wakunaga Pharmaceutical Co., Ltd | Novel indole derivatives and drugs containing the same as the active ingredient |
| WO2001034146A1 (en) * | 1999-11-08 | 2001-05-17 | Smithkline Beecham Corporation | Novel anti-infectives |
| DE19963178A1 (en) | 1999-12-27 | 2001-07-05 | Gruenenthal Gmbh | Substituted indole Mannich bases |
| WO2001055361A2 (en) | 2000-01-26 | 2001-08-02 | Chiron Corporation | Recombinant aav packaging systems |
| JP2005526691A (en) * | 2001-08-08 | 2005-09-08 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | Therapeutic agent 1H-pyrido [4,3-b] indole |
| DE10209520A1 (en) * | 2002-03-04 | 2003-09-25 | 4Sc Ag | New modulators of potassium channels |
| US6906095B2 (en) | 2002-05-10 | 2005-06-14 | Wyeth | Indolylalkylidenehydrazine-carboximidamide derivatives as 5-hydroxytryptamine-6 ligands |
| US6951881B2 (en) | 2002-05-10 | 2005-10-04 | Wyeth | (1-substituted-indol-3-yl) alkylidenehydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands |
| US7423044B2 (en) * | 2002-09-05 | 2008-09-09 | Wyeth | Pyrimidine derivatives useful in the treatment of insulin resistance and hyperglycemia |
| CA2508290C (en) | 2002-12-20 | 2017-02-28 | Ciba Specialty Chemicals Holding Inc. | Synthesis of amines and intermediates for the synthesis thereof |
| KR20070083484A (en) * | 2004-07-14 | 2007-08-24 | 피티씨 테라퓨틱스, 인크. | Methods for treating hepatitis c |
| US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| WO2010034671A1 (en) * | 2008-09-26 | 2010-04-01 | F. Hoffmann-La Roche Ag | Pyrine or pyrazine derivatives for treating hcv |
| SG177628A1 (en) | 2009-07-30 | 2012-03-29 | Univ Singapore | Small molecule inhibitors of isoprenylcysteine carboxyl methyltransferase with potential anticancer activity |
| CN114249681A (en) * | 2021-11-22 | 2022-03-29 | 宁波大学 | 7-fluoro-5-substituted tryptamine compound and preparation method and application thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4833153A (en) * | 1985-11-08 | 1989-05-23 | Glaxo Group Limited | Indole derivatives |
| GB8724912D0 (en) * | 1987-10-23 | 1987-11-25 | Wellcome Found | Indole derivatives |
| IL96891A0 (en) * | 1990-01-17 | 1992-03-29 | Merck Sharp & Dohme | Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them |
| SK278998B6 (en) * | 1991-02-01 | 1998-05-06 | Merck Sharp & Dohme Limited | Imidazole, triazole and tetrazole derivatives, method of producing same, their use and pharmaceutical compositons on their base |
| TW263508B (en) * | 1991-02-12 | 1995-11-21 | Pfizer | |
| HUT64023A (en) * | 1991-03-22 | 1993-11-29 | Sandoz Ag | Process for producing aminoguanidine derivatives and pharmaceutical compositions comprising such compounds |
-
1992
- 1992-12-21 GB GB929226537A patent/GB9226537D0/en active Pending
-
1993
- 1993-12-14 JP JP6514774A patent/JPH08504786A/en active Pending
- 1993-12-14 EP EP94903794A patent/EP0674620A1/en not_active Withdrawn
- 1993-12-14 AU AU58119/94A patent/AU5811994A/en not_active Abandoned
- 1993-12-14 WO PCT/EP1993/003564 patent/WO1994014771A1/en not_active Application Discontinuation
- 1993-12-17 ZA ZA939456A patent/ZA939456B/en unknown
- 1993-12-20 CN CN93112761A patent/CN1092765A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1092765A (en) | 1994-09-28 |
| WO1994014771A1 (en) | 1994-07-07 |
| GB9226537D0 (en) | 1993-02-17 |
| AU5811994A (en) | 1994-07-19 |
| JPH08504786A (en) | 1996-05-21 |
| EP0674620A1 (en) | 1995-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9300508A0 (en) | Compounds | |
| GB9209628D0 (en) | Compounds | |
| GB9201755D0 (en) | Compounds | |
| GB9200210D0 (en) | Compounds | |
| GB9201694D0 (en) | Compounds | |
| GB9201693D0 (en) | Compounds | |
| GB9200209D0 (en) | Compounds | |
| GB9210632D0 (en) | Compounds | |
| GB9200566D0 (en) | Compounds | |
| GB9201751D0 (en) | Compounds | |
| GB9202792D0 (en) | Compounds | |
| GB9205859D0 (en) | Compounds | |
| GB9203174D0 (en) | Compounds | |
| GB9205563D0 (en) | Compounds | |
| GB9201748D0 (en) | Compounds | |
| GB9201819D0 (en) | Compounds | |
| GB9201747D0 (en) | Compounds | |
| GB9202827D0 (en) | Compounds | |
| GB9202991D0 (en) | Compounds | |
| GB9208790D0 (en) | Compounds | |
| GB9203170D0 (en) | Compounds | |
| GB9203171D0 (en) | Compounds | |
| GB9203172D0 (en) | Compounds | |
| GB9203173D0 (en) | Compounds | |
| GB9208871D0 (en) | Compounds |